Keymed Biosciences Inc. (HKG:2162)

Keymed Biosciences Statistics

Total Valuation

HKG:2162 has a market cap or net worth of HKD 17.84 billion. The enterprise value is 16.58 billion.

Market Cap	17.84B
Enterprise Value	16.58B

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2162 has 294.60 million shares outstanding. The number of shares has increased by 4.46% in one year.

Current Share Class	294.60M
Shares Outstanding	294.60M
Shares Change (YoY)	+4.46%
Shares Change (QoQ)	+0.75%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	23.60%
Float	219.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.38
PB Ratio	5.78
P/TBV Ratio	5.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-28.50
EV / Sales	20.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.28.

Current Ratio	2.90
Quick Ratio	2.42
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-39.17

Financial Efficiency

Return on equity (ROE) is -19.91% and return on invested capital (ROIC) is -12.19%.

Return on Equity (ROE)	-19.91%
Return on Assets (ROA)	-10.37%
Return on Invested Capital (ROIC)	-12.19%
Return on Capital Employed (ROCE)	-19.59%
Weighted Average Cost of Capital (WACC)	3.58%
Revenue Per Employee	542,628
Profits Per Employee	-395,916
Employee Count	1,469
Asset Turnover	0.18
Inventory Turnover	0.55

Taxes

In the past 12 months, HKG:2162 has paid 2.09 million in taxes.

Income Tax	2.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.95% in the last 52 weeks. The beta is -0.10, so HKG:2162's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	+48.95%
50-Day Moving Average	54.76
200-Day Moving Average	59.55
Relative Strength Index (RSI)	65.33
Average Volume (20 Days)	2,270,266

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2162 had revenue of HKD 797.12 million and -581.60 million in losses. Loss per share was -2.13.

Revenue	797.12M
Gross Profit	699.14M
Operating Income	-737.09M
Pretax Income	-579.47M
Net Income	-581.60M
EBITDA	-653.61M
EBIT	-737.09M
Loss Per Share	-2.13

Balance Sheet

The company has 2.14 billion in cash and 877.50 million in debt, with a net cash position of 1.26 billion or 4.29 per share.

Cash & Cash Equivalents	2.14B
Total Debt	877.50M
Net Cash	1.26B
Net Cash Per Share	4.29
Equity (Book Value)	3.09B
Book Value Per Share	10.91
Working Capital	1.77B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	85.01M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 87.71%, with operating and profit margins of -92.47% and -72.96%.

Gross Margin	87.71%
Operating Margin	-92.47%
Pretax Margin	-72.69%
Profit Margin	-72.96%
EBITDA Margin	-82.00%
EBIT Margin	-92.47%
FCF Margin	n/a

Dividends & Yields

HKG:2162 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.46%
Shareholder Yield	-4.46%
Earnings Yield	-3.26%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1